Because GLP-1 medications remain active in the body for several days, taking a dose slightly later than usual usually does not cause major disruption
one of the label-defining trials for any cardiometabolic claim.) ClinicalTrials.gov
In conclusion, the addition of semaglutide injections to lifestyle and metformin interventions can reduce BMI, waist and hip circumference, and body fat percentage, alleviate hyperandrogenemia, improve glucose metabolism and insulin resistance, and promote the restoration of normal menstrual cycles without exacerbating negative psychological emotions in individuals living with overweight/obesity and PCOS-related infertility
[5] [6] The medication works by mimicking the action of endogenous GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways